| Spontaneous preterm delivery after sampling | P-value | |
---|---|---|---|
≤48 h (n = 26) | > 48 h (n = 147) | ||
Maternal age (years) | 33.0 ± 4.0 | 31.3 ± 4.0 | 0.047 |
Nulliparity | 35% (9) | 66% (97) | 0.003 |
Gestational age at sampling (weeks) | 30.7 ± 2.6 | 30.0 ± 2.7 | 0.195 |
Gestational age at delivery (weeks) | 30.7 ± 2.5 | 36.1 ± 4.0 | <  0.001 |
Serum C-reactive protein (mg/L) | 14.3 ± 15.2 | 8.2 ± 13.4 | 0.003 |
Cervical length on ultrasonography (mm) | 13.8 ± 10.9 | 26.7 ± 11.1 | < 0.001 |
Plasma C3a (μg/mL) | 12.9 ± 7.9 | 12.9 ± 7.7 | 0.863 |
Plasma C5a (ng/mL) | 41.0 ± 14.0 | 45.6 ± 12.5 | 0.237 |
Plasma interleukin-6 (pg/mL) | 11.7 ± 12.0 | 4.0 ± 4.2 | < 0.001 |
Plasma matrix metalloproteinase-9 (ng/mL) | 251.0 ± 253.9 | 207.6 ± 175.9 | 0.858 |
Use of tocolytic agents | 89% (23) | 95% (139) | 0.242 |
Use of antibiotics | 27% (7) | 31% (45) | 0.706 |
Use of antenatal corticosteroids | 89% (23) | 76% (112) | 0.165 |
Clinical chorioamnionitis | 3.8% (1) | 0% (0) | 0.017 |
Histological chorioamnionitisa | 50% (13/26) | 35% (26/75) | 0.169 |
Positive amniotic fluid cultures | 19% (5) | 7.5% (11) | 0.057 |
Amniotic fluid interleukin-6 (ng/mL) | 11.7 ± 21.4 | 2.8 ± 8.9 | < 0.001 |